Post by Ypsomed AG

Name: As demand for GLP-1 and peptide therapies continues to grow, delivery platforms need to support both
Uploaded: 2026-06-12T06:31:03.658Z
Channel: Ypsomed AG
Description: As demand for GLP-1 and peptide therapies continues to grow, delivery platforms need to support both originator and biosimilar products across chronic care applications 📈. YpsoFlow was developed as

39,865 followers

As demand for GLP-1 and peptide therapies continues to grow, delivery platforms need to support both originator and biosimilar products across chronic care applications 📈. YpsoFlow was developed as a flexible pen platform, supporting a smooth path to market across therapies 🚀. Built on more than 40 years of expertise and reliability in pen delivery, YpsoFlow combines proven experience with the flexibility needed for evolving market demands ✨. #YpsoFlow #GLP1 #PeptideTherapies #DrugDelivery #ypsomed

Video Content